MEG3 and breast cancer: Results presented in Table 2 indicated that the frequencies of MEG3 rs7158663 GA/AA genotype and A allele were significantly higher in BC patients than controls (65% vs. 38%, χ2 = 25.16, p ≤ 0.0001 and 72.8% vs. 30%, χ2= 120.71, p ≤ 0.0001, respectively).